NOCAD (n = 7478) | CAD (n = 10,906) | p-value* | |
---|---|---|---|
Age, mean years | 58.8 ± 10.9 | 64.0 ± 10.2 | < 0.001 |
Female (%) | 3517 (47%) | 2514 (23.1%) | < 0.001 |
EF calculated (n = 2599) | 64.9 ± 7.5 | 63.7 ± 12.6 | < 0.001 |
Normal coronary arteries | 49.4% | N/A | N/A |
Cardiovascular risk factors: | |||
Hypertension (%) | 60.4 | 72.1 | < 0.001 |
Dyslipidemia (%) | 65.6 | 79.2 | < 0.001 |
Diabetes mellitus (%) | 16.8 | 26.6 | < 0.001 |
Smoker- current/ previous (%) | 52.5 | 61.6 | 0.04 |
Current smoker (%) | 17.7 | 18.9 | < 0.001 |
Positive family history (%) | 29.6 | 29.1 | 0.47 |
Medications at time of cath: | |||
Aspirin | 5286/7159 (73.8%) | 8940/10555 (84.7%) | < 0.001 |
P2Y12 Inhibitor | 480/6878 (7%) | 1105/10078 (11.0%) | < 0.001 |
Beta-blockers | 3561/7060 (50.4%) | 6626/10423 (63.6%) | < 0.001 |
Statins | 3285/6926 (47.4%) | 6681/10048 (66.5%) | < 0.001 |
Calcium channel blockers | 1269/6911 (18.4%) | 2343/10115 (23.2%) | < 0.001 |
ACE-inhibitor | 1957/6969 (28.1%) | 3983/10429 (38.2%) | < 0.001 |
Long acting nitrates | 867/6862 (12.6%) | 1716/ 10,043 (7.1%) | < 0.001 |
Insulin | 193/5760 (3.4%) | 445/8442 (5.3%) | < 0.001 |